Is Greenwich LifeSciences, Inc. (GLSI) a Buy, Sell, or Hold?
NASDAQ : GLSI
Greenwich LifeSciences, Inc.
$19.54 USD
$0.53 (2.79%)
- Volume
- 46.62K
- Average Volume
- 144.58K
- Market Capitalization
- $286.81M
- P/E Ratio
- -12.45
- Dividend Yield
- 0.00%
- Price Target
- $50.00
- Year High
- $34.10
- Year Low
- $7.78
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $2.01
NUMBER OF INSIDERS BUYING (LAST 12 MONTHS)
18
NUMBER OF INSIDERS SELLING (LAST 12 MONTHS)
0
AMOUNT OF INSIDER SELLING (LAST 12 MONTHS)
-$
GLSI Estimated and Actual Revenue by Quarter
Get MSFT Insider Trade Alerts
GLSI Insider Trading History
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| Patel Snehal | director, 10 percent owner, officer: CEO and CFO | 2026-01-13 | P-Purchase | 29.83 | 2026-01-15 |
| Patel Snehal | director, 10 percent owner, officer: CEO and CFO | 2026-01-12 | P-Purchase | 27.54 | 2026-01-14 |
| Patel Snehal | director, 10 percent owner, officer: CEO and CFO | 2025-12-31 | P-Purchase | 21.36 | 2026-01-05 |
| Patel Snehal | director, 10 percent owner, officer: CEO and CFO | 2025-12-30 | P-Purchase | 21.73 | 2026-01-02 |
| Patel Snehal | director, 10 percent owner, officer: CEO and CFO | 2025-12-18 | P-Purchase | 12.62 | 2025-12-19 |
| Patel Snehal | director, 10 percent owner, officer: CEO and CFO | 2025-11-25 | P-Purchase | 8.37 | 2025-11-28 |
| Patel Snehal | director, 10 percent owner, officer: CEO and CFO | 2025-11-13 | A-Award | 8.2 | 2025-11-17 |
| Patel Snehal | director, 10 percent owner, officer: CEO and CFO | 2025-11-07 | P-Purchase | 8.43 | 2025-11-12 |
| Patel Snehal | director, 10 percent owner, officer: CEO and CFO | 2025-10-31 | P-Purchase | 9.26 | 2025-11-04 |
| Patel Snehal | director, 10 percent owner, officer: CEO and CFO | 2025-04-25 | P-Purchase | 9.88 | 2025-04-29 |
| Patel Snehal | director, 10 percent owner, officer: CEO and CFO | 2025-04-17 | P-Purchase | 8.98 | 2025-04-22 |
| Patel Snehal | director, 10 percent owner, officer: CEO and CFO | 2025-04-07 | P-Purchase | 9.1 | 2025-04-08 |
| Patel Snehal | director, 10 percent owner, officer: CEO and CFO | 2025-04-04 | P-Purchase | 8.73 | 2025-04-07 |
| Patel Snehal | director, 10 percent owner, officer: CEO and CFO | 2025-01-10 | P-Purchase | 12.51 | 2025-01-13 |
| Patel Snehal | director, 10 percent owner, officer: CEO and CFO | 2025-01-07 | P-Purchase | 13.75 | 2025-01-08 |
| Patel Snehal | director, 10 percent owner, officer: CEO and CFO | 2025-01-06 | P-Purchase | 13.31 | 2025-01-08 |
| Patel Snehal | director, 10 percent owner, officer: CEO and CFO | 2025-01-03 | P-Purchase | 12.95 | 2025-01-07 |
| Patel Snehal | director, 10 percent owner, officer: CEO and CFO | 2025-01-02 | P-Purchase | 11.97 | 2025-01-06 |
| Patel Snehal | director, 10 percent owner, officer: CEO and CFO | 2024-12-31 | P-Purchase | 11.36 | 2025-01-03 |
| Patel Snehal | director, 10 percent owner, officer: CEO and CFO | 2024-12-30 | P-Purchase | 11.12 | 2025-01-02 |
| Daugherty Frank Joseph | director, officer: Chief Medical Officer | 2024-12-24 | A-Award | 12.16 | 2024-12-27 |
| Hallock Kenneth | director | 2024-12-24 | A-Award | 12.16 | 2024-12-27 |
| Patel Snehal | director, 10 percent owner, officer: CEO and CFO | 2024-12-24 | A-Award | 12.16 | 2024-12-27 |
| Patel Snehal | director, 10 percent owner, officer: CEO and CFO | 2024-12-24 | A-Award | 12.16 | 2024-12-27 |
| Rothe Eric | director | 2024-12-24 | A-Award | 12.16 | 2024-12-27 |
| Thompson Jaye | officer: VP Clinical Reg Affairs | 2024-12-24 | A-Award | 12.16 | 2024-12-27 |
| McWilliams David | director | 2024-12-24 | A-Award | 12.16 | 2024-12-27 |
| Thompson Jaye | officer: VP Clinical Reg Affairs | 2024-11-21 | P-Purchase | 12.91 | 2024-11-25 |
| Patel Snehal | director, 10 percent owner, officer: CEO and CFO | 2024-09-26 | P-Purchase | 14.63 | 2024-09-30 |
| Thompson Jaye | officer: VP Clinical Reg Affairs | 2024-08-12 | P-Purchase | 13.85 | 2024-09-16 |
| Patel Snehal | director, 10 percent owner, officer: CEO and CFO | 2024-08-06 | P-Purchase | 13.81 | 2024-08-08 |
| Patel Snehal | director, 10 percent owner, officer: CEO and CFO | 2024-08-05 | P-Purchase | 13.18 | 2024-08-07 |
| Thompson Jaye | officer: VP Clinical Reg Affairs | 2024-08-02 | P-Purchase | 15.15 | 2024-08-05 |
| Patel Snehal | director, 10 percent owner, officer: CEO and CFO | 2024-07-23 | P-Purchase | 15.89 | 2024-07-24 |
| Thompson Jaye | officer: VP Clinical Reg Affairs | 2024-07-18 | P-Purchase | 16 | 2024-07-22 |
| Patel Snehal | director, 10 percent owner, officer: CEO and CFO | 2024-06-13 | P-Purchase | 14.3 | 2024-06-17 |
| Patel Snehal | director, 10 percent owner, officer: CEO and CFO | 2024-04-01 | P-Purchase | 19.08 | 2024-04-03 |
| Patel Snehal | director, 10 percent owner, officer: CEO and CFO | 2024-03-22 | P-Purchase | 19.98 | 2024-03-26 |
| Patel Snehal | director, 10 percent owner, officer: CEO and CFO | 2024-03-20 | P-Purchase | 17.68 | 2024-03-22 |
| Patel Snehal | director, 10 percent owner, officer: CEO and CFO | 2024-03-05 | P-Purchase | 12.49 | 2024-03-07 |
| Patel Snehal | director, 10 percent owner, officer: CEO and CFO | 2024-03-04 | P-Purchase | 13.03 | 2024-03-06 |
| Patel Snehal | director, 10 percent owner, officer: CEO and CFO | 2024-02-16 | P-Purchase | 11.16 | 2024-02-21 |
| Patel Snehal | director, 10 percent owner, officer: CEO and CFO | 2024-02-15 | P-Purchase | 11.07 | 2024-02-20 |
| Patel Snehal | director, 10 percent owner, officer: CEO and CFO | 2023-11-10 | P-Purchase | 10.1675 | 2023-11-14 |
| Patel Snehal | director, 10 percent owner, officer: CEO and CFO | 2023-11-03 | P-Purchase | 9.11 | 2023-11-07 |
| Thompson Jaye | officer: VP Clinical Reg Affairs | 2023-10-27 | P-Purchase | 8.57 | 2023-10-31 |
| Patel Snehal | director, 10 percent owner, officer: CEO and CFO | 2023-10-26 | P-Purchase | 7.97 | 2023-10-30 |
| Patel Snehal | director, 10 percent owner, officer: CEO and CFO | 2023-10-25 | P-Purchase | 7.91 | 2023-10-27 |
| Patel Snehal | director, 10 percent owner, officer: CEO and CFO | 2023-10-10 | P-Purchase | 9.07 | 2023-10-12 |
| Patel Snehal | director, 10 percent owner, officer: CEO and CFO | 2023-10-04 | P-Purchase | 8.63 | 2023-10-05 |
| Thompson Jaye | officer: VP Clinical Reg Affairs | 2023-09-26 | P-Purchase | 8.71 | 2023-09-28 |
| Patel Snehal | director, 10 percent owner, officer: CEO and CFO | 2023-09-19 | P-Purchase | 8.95 | 2023-09-21 |
| Patel Snehal | director, 10 percent owner, officer: CEO and CFO | 2023-09-11 | P-Purchase | 9.48 | 2023-09-13 |
| Patel Snehal | director, 10 percent owner, officer: CEO and CFO | 2023-08-22 | P-Purchase | 9.97 | 2023-08-24 |
| Patel Snehal | director, 10 percent owner, officer: CEO and CFO | 2023-08-04 | P-Purchase | 10.55 | 2023-08-08 |
| Patel Snehal | director, 10 percent owner, officer: CEO and CFO | 2023-07-21 | P-Purchase | 9.2 | 2023-07-25 |
| Thompson Jaye | officer: VP Clinical Reg Affairs | 2023-07-13 | P-Purchase | 9.49 | 2023-07-17 |
| Patel Snehal | director, 10 percent owner, officer: CEO and CFO | 2023-05-17 | P-Purchase | 11.69 | 2023-05-18 |
| Thompson Jaye | officer: VP Clinical Reg Affairs | 2023-04-28 | P-Purchase | 11.22 | 2023-05-02 |
| Patel Snehal | director, 10 percent owner, officer: CEO and CFO | 2023-04-19 | P-Purchase | 11.1 | 2023-04-21 |
| Patel Snehal | director, 10 percent owner, officer: CEO and CFO | 2023-04-18 | P-Purchase | 11.12 | 2023-04-20 |
| Thompson Jaye | officer: VP Clinical Reg Affairs | 2023-04-11 | P-Purchase | 11.87 | 2023-04-12 |
| Patel Snehal | director, 10 percent owner, officer: CEO and CFO | 2023-04-11 | P-Purchase | 12.42 | 2023-04-12 |
| Thompson Jaye | officer: VP Clinical Reg Affairs | 2023-03-15 | P-Purchase | 12.71 | 2023-03-16 |
| Patel Snehal | director, 10 percent owner, officer: CEO and CFO | 2023-03-10 | P-Purchase | 12.12 | 2023-03-13 |
| Thompson Jaye | officer: VP Clinical Reg Affairs | 2023-02-24 | P-Purchase | 15.395 | 2023-02-28 |
| Patel Snehal | director, 10 percent owner, officer: CEO and CFO | 2023-02-17 | P-Purchase | 16.53 | 2023-02-22 |
| Patel Snehal | director, 10 percent owner, officer: CEO and CFO | 2023-02-10 | P-Purchase | 18.68 | 2023-02-14 |
| Thompson Jaye | officer: VP Clinical Reg Affairs | 2023-02-03 | P-Purchase | 20.84 | 2023-02-07 |
| Patel Snehal | officer: CEO and CFO | 2023-01-27 | P-Purchase | 19.35 | 2023-01-31 |
| Thompson Jaye | officer: VP Clinical Reg Affairs | 2023-01-27 | P-Purchase | 19.2 | 2023-01-30 |
| Patel Snehal | officer: CEO and CFO | 2023-01-20 | P-Purchase | 17.37 | 2023-01-24 |
| Thompson Jaye | officer: VP Clinical Reg Affairs | 2023-01-13 | P-Purchase | 16.5 | 2023-01-17 |
| Patel Snehal | officer: CEO and CFO | 2023-01-06 | P-Purchase | 15.18 | 2023-01-10 |
| Patel Snehal | officer: CEO and CFO | 2022-12-29 | P-Purchase | 15.19 | 2023-01-03 |
| Patel Snehal | officer: CEO and CFO | 2022-12-16 | P-Purchase | 13.01 | 2022-12-20 |
| Thompson Jaye | officer: VP Clinical Reg Affairs | 2022-12-16 | P-Purchase | 12.94 | 2022-12-20 |
| Patel Snehal | officer: CEO and CFO | 2022-12-09 | P-Purchase | 13.11 | 2022-12-13 |
| Patel Snehal | officer: CEO and CFO | 2022-12-02 | P-Purchase | 13.84 | 2022-12-06 |
| Thompson Jaye | officer: VP Clinical Reg Affairs | 2022-12-02 | P-Purchase | 13.98 | 2022-12-06 |
| Patel Snehal | officer: CEO and CFO | 2022-11-02 | P-Purchase | 8.79 | 2022-11-04 |
| Patel Snehal | officer: CEO and CFO | 2022-10-14 | P-Purchase | 9.75 | 2022-10-17 |
| Patel Snehal | officer: CEO and CFO | 2022-10-07 | P-Purchase | 9.72 | 2022-10-11 |
| Patel Snehal | officer: CEO and CFO | 2022-09-30 | P-Purchase | 9.46 | 2022-10-04 |
| Patel Snehal | officer: CEO and CFO | 2022-09-29 | P-Purchase | 9.23 | 2022-10-03 |
| Patel Snehal | officer: CEO and CFO | 2022-06-24 | P-Purchase | 9.13 | 2022-06-27 |
| Daugherty Frank Joseph | director, officer: Chief Medical Officer | 2022-06-22 | A-Award | 7.63 | 2022-06-24 |
| Daugherty Frank Joseph | officer: Chief Medical Officer | 2022-06-22 | A-Award | 0 | 2022-06-24 |
| Patel Snehal | officer: CEO and CFO | 2022-06-22 | A-Award | 0 | 2022-06-24 |
| Thompson Jaye | officer: VP Clinical Reg Affairs | 2022-06-22 | A-Award | 0 | 2022-06-24 |
| Hallock Kenneth | director | 2022-06-22 | A-Award | 7.63 | 2022-06-24 |
| Hallock Kenneth | director: | 2022-06-22 | A-Award | 0 | 2022-06-24 |
| Rothe Eric | director: | 2022-06-22 | A-Award | 0 | 2022-06-24 |
| McWilliams David | director: | 2022-06-22 | A-Award | 0 | 2022-06-24 |
| Patel Snehal | officer: CEO and CFO | 2022-06-16 | P-Purchase | 7.13 | 2022-06-17 |
| Patel Snehal | officer: CEO and CFO | 2022-06-14 | P-Purchase | 7.91 | 2022-06-15 |
| Patel Snehal | officer: CEO and CFO | 2022-06-10 | P-Purchase | 8.33 | 2022-06-13 |
| Patel Snehal | officer: CEO and CFO | 2022-06-09 | P-Purchase | 10.9 | 2022-06-10 |
| Patel Snehal | officer: CEO and CFO | 2022-06-07 | P-Purchase | 8.55 | 2022-06-08 |
| Patel Snehal | officer: CEO and CFO | 2022-06-03 | P-Purchase | 8.35 | 2022-06-06 |